retatrutide phase 2 trial obesity nejm 2023 triple agonist (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Retatrutide Week by Week: Weight

Reputable companies will provide labeling information for each batch of medication, so if a problem with a certain batch is discovered, youll know whether your supply is safe to use

BPC-157 is not FDA-approved as a drug or dietary supplement

Nature 528 (7581), 262266

While marijuana isn't strong enough for severe pain (for example, post-surgical pain or a broken bone), it is quite effective for the chronic pain that plagues millions of Americans, especially as they age

GLP-2 prevents neuronal and glial changes in the distal colon of mice chronically treated with cisplatin

View Full Study Biological activity versus physiological function of proinsulin C-peptide